Sentences with phrase «causing macular»

These studies have indicated that repeated doses of anti-VEGF medications, such as ranibizumab, may prevent blood vessels from leaking fluid and causing macular edema.

In the past 10 years, the chromosomal locations of at least 10 genes that cause macular - degenerationlike conditions have been identified, and three of the genes have actually been identified.

Not exact matches

Studies show that lutein and zeaxanthin can benefit eye health by decreasing the risk of cataracts and age - related macular degeneration, two common causes of vision loss in older adults (36).

Lutein and zeaxanthin, two antioxidants found in egg yolks, help prevent macular degeneration, a leading cause of age - related blindness.

They also reduce the risk for age - related macular degeneration, the leading cause of blindness among older adults.

Over time, this exposure leads to retinal damage, including Age - related Macular Degeneration (AMD), which is the leading cause of blindness for people over age 50.

The study included 18 patients, half with age - related macular degeneration and half with Stargardt's macular dystrophy, the leading causes of blindness in adults and juveniles.

The earlier diabetic retinopathy, macular degeneration and glaucoma — the three most prevalent diseases causing blindness — can be diagnosed, the more successfully they can be treated.

A man in a flagship stem cell trial for age - related macular degeneration has swelling in his eye, but the cause is probably surgery — not stem cells

According to a smaller study, running also reduces the risk of macular degeneration — the leading cause of blindness in developed countries.

The other, the «dry» form of age - related macular degeneration, is the most common cause of age - related blindness.

Macular degeneration is the most common cause of blindness in the west — but a host of pioneering therapies that exploit the eye's unique structure could change that

It took the form of a molecule that might attack the wet form of macular degeneration — a major cause of blindness in older individuals — without causing unpleasant side effects.

A new technique reported in the February 2015 issue of The FASEB Journal suggests that during early stages, it might be possible to reverse age - related macular degeneration, a leading cause of blindness that is currently irreversible.

For people over 50, age - related macular degeneration (AMD) affects about 15 million Americans and remains the leading cause of vision loss in the entire Western world, according to Abdhish Bhavsar, director of clinical research at the Retina Center of Minnesota.

The study, published online ahead of print in The Journal of Clinical Investigation, has implications for treating diseases such as diabetic retinopathy and age - related macular degeneration — the leading causes of vision loss in adults.

In the coming weeks, ACT will apply to the FDA to conduct a separate trial in age - related macular degeneration, in which ageing of RPEs eventually causes blindness, a condition affecting 30 million people worldwide.

This is the case with age - related macular degeneration — a «wet» version of which causes vision loss in the center of the eye — and diabetic retinopathy — in which some people with diabetes develop blurry or patchy vision.

The device can treat either form of age - related macular degeneration: the dry stage, where the delicate tissues of the macula become thinned and slowly lose function, or the less common wet stage that's caused by the growth of abnormal blood vessels behind the macula.

New devices provide hope of stopping and reversing damage caused by age - related macular degeneration

Those suffering from advanced stages of macular degeneration may by the end of this year be able to halt and even reverse vision loss caused by the age - related eye disease.

Macular degeneration is a disorder of the central retina, or macula, that causes the afflicted person to see a dark spot in the center of his or her field of vision, impairing the ability to read, recognize faces and watch TV.

Duke Researchers have pinpointed a new therapeutic target for macular degeneration, an eye disease that affects over 10 million Americans and is the leading cause of blindness in adults over 60.

Cataract was the next main cause in this region, with 15.5 %, followed by age - related macular degeneration.

Dr. Chew leads the Age - Related Eye Disease Study (AREDS), which was designed to investigate a combination of nutritional supplements for slowing age - related macular degeneration (AMD), a major cause of vision loss among older Americans.

The results could eventually be relevant to the treatment of a much more common cause of blindness, age - related macular degeneration, which is caused by whole host of faulty genes.

Their results could be relevant to the treatment of a more common cause of blindness, age - related macular degeneration, which is caused by a host of faulty genes.

Both drugs are about equally effective at treating macular degeneration, the leading cause of visual impairment in older adults.

Age - related macular degeneration is the leading cause of blindness in the elderly.

Age - related macular degeneration is the leading cause of irreversible vision impairment in older adults in the United States, yet little is known about whether AMD is appropriately diagnosed in primary eye care.

Two of these drugs use RNAi to shut down genes involved in macular degeneration, the leading cause of blindness in the elderly, and a third disables a deadly pneumonia - causing virus.

Many diseases that lead to blindness, such as glaucoma and macular degeneration, are caused by the death of certain cells in the human retina that lack the ability to regenerate.

It has been designed for treating the «dry» form of macular degeneration, caused by deposits on the retina gradually killing retinal pigment epithelial cells, which support light - capturing cells.

In a second trial starting around the same time, a different team in Zhengzhou will use ES cells to target vision loss caused by age - related macular degeneration.

Another important group of possible causes of age - related macular degeneration is mildly abnormal genes.

Along with age - related macular degeneration, diabetic retinal degeneration is one of the most common causes of blindness.

The leading cause of blindness among older adults in the United States is age - related macular degeneration (AMD).

Although some of these factors appear to have a demonstrable effect on prevalence or course of macular degeneration (green leafy vegetables are good, cigarettes are bad), none has emerged as a likely major cause of it.

It is important for all patients (and family members of patients) with macular degeneration to know that although the disease can injure the central vision of both eyes severely enough to render one «legally blind,» it is extremely uncommon to cause complete blindness in even a single eye.

Physicians have wondered about the causes of macular degeneration for over a century.

It is widely accepted that age - related macular degeneration (AMD) is the most common cause of visual impairment and blindness in industrialized countries.

When a disease like macular degeneration is caused by a dominant gene, a number of family members may be similarly affected.

There may be a connection between taking vasodilators and developing early - stage age - related macular degeneration (AMD), the leading cause of vision loss and blindness among Americans who are age 65 and older, according to a study published online in Ophthalmology, the journal of the American Academy of Ophthalmology.

An international study, involving researchers at the University of Southampton and Southampton General Hospital, has significantly expanded the number of genetic factors known to play a role in age - related macular degeneration (AMD), a leading cause of vision loss among people age 50 and older.

Loss of, or diminished, retinal DHA leads to visual impairment and may play an important role in the development of blindness from retinitis pigmentosa and other retinal degenerative diseases, as well as age - related macular degeneration (AMD), the foremost cause of blindness in people older than 50 years.

Each year, around 2.5 million people worldwide develop macular degeneration and it is the commonest cause of blindness in industrialised countries.

Researchers at Massachusetts Eye and Ear / Harvard Medical School and the University of Crete have conducted a phase I / II clinical trial investigating the efficacy of statins (cholesterol - lowering medications) for the treatment of patients with the dry form of age - related macular degeneration (AMD)-- the leading cause of blindness in the developed world.

Age - related macular degeneration is the leading cause of blindness in older adults in the United States.

Unlike some other common vision disorders, such as age - related macular degneration, color blindness is a heritable disorder caused by a single gene that is defective or absent.

Age - related macular degeneration, a disease that slowly degrades light - sensitive cells in the retina, is the leading cause of vision loss and blindness among people 65 and older, according to the Centers for Disease Control...